Dr. Ian Corbin received his Bachelor’s of Science degree in 1994 from the University of Winnipeg, Canada. He then went on to earn a Masters of Science from the University of Manitoba in the Department of Anatomy and Cell Sciences where he used high resolution NMR to study metabolic interactions between parasitic cestodes and their murine hosts. Thereafter, Dr. Corbin continued at the University of Manitoba to earn his doctorate in Pharmacology and Therapeutics in 2002. His thesis dissertation focused on the use of in vivo31P MRS as a diagnostic tools for assessing the severity of liver disease. After completing his PhD Dr. Corbin spent four years as a Postdoctoral Fellow at the University of Pennsylvania in the Department of Radiology where he began working in the field of nanotechnology. In 2006, he was appointed as a Scientific Associate at the University Health Network, Division of Biophysics and Bioimaging, Toronto, Canada. At this center Dr. Corbin continued to develop expertise and expand his investigations in the area of diagnostic and therapeutic nanomedicine. In 2009, Dr. Corbin returned to the United States where he accepted a position as an Assistant Professor in the Advanced Imaging Research Center at the University of Texas Southwestern Medical Center. Dr. Corbin’s lab currently focuses on image guided strategies for nanomedicine based drug delivery.